Teofilin Zehirlenmesinde Hemoperfüzyon: Olgu Sunumu

Cilt: 40 Sayı: 2 1 Haziran 2014
PDF İndir
EN TR

Hemoperfusion for Theophylline Poisoning: Case Report

Öz

Theophylline is a methylxanthine derivative which is used in the treatment of bronchospastic pulmonary diseases. The therapeutic range of theophylline is very narrow. It carries a risk for intoxication when the blood level is over 15μg/mL. Serious theophylline poisoning should be treated in intensive care conditions as it may cause fatal consequences. In these cases, gastric lavage, active charcoal administration through a nasogastric tube and symptomatic treatments can be applied. If these treatments are unsuccessful, extracorporeal methods like hemodialysis or charcoal hemoperfusion can be applied. We present two cases which were unresponsive to method of classic treatment and treated with hemoperfusion after theophylline intoxication. The first case presented with nausea, vomiting, and tremor refractory to treatment. The second case experienced extensive episodes of hypotension, atrial fibrillation, tonic clonic seizures and finally cardio pulmonary arrest. Cardiopul-monary ressuciation was successful. Both cases were successfully discharged from the intensive care unit after hemoperfusion therapy. In conclusion, hemoperfusion with active charcoal filters is a successful method for reducing serum theophylline concentration in patients unresponsive to classic supportive treatment.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Nermin Kelebek Girgin Bu kişi benim

Bülent Gül Bu kişi benim

Remzi İşçimen Bu kişi benim

Ferda Kahveci Bu kişi benim

Yayımlanma Tarihi

1 Haziran 2014

Gönderilme Tarihi

1 Haziran 2014

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2014 Cilt: 40 Sayı: 2

Kaynak Göster

APA
Çalışkan, G., Girgin, N. K., Uran, İ., Gül, B., İşçimen, R., & Kahveci, F. (2014). Hemoperfusion for Theophylline Poisoning: Case Report. Journal of Uludağ University Medical Faculty, 40(2), 89-93. https://izlik.org/JA98RB72ZA
AMA
1.Çalışkan G, Girgin NK, Uran İ, Gül B, İşçimen R, Kahveci F. Hemoperfusion for Theophylline Poisoning: Case Report. Uludağ Tıp Derg. 2014;40(2):89-93. https://izlik.org/JA98RB72ZA
Chicago
Çalışkan, Gülbahar, Nermin Kelebek Girgin, İsa Uran, Bülent Gül, Remzi İşçimen, ve Ferda Kahveci. 2014. “Hemoperfusion for Theophylline Poisoning: Case Report”. Journal of Uludağ University Medical Faculty 40 (2): 89-93. https://izlik.org/JA98RB72ZA.
EndNote
Çalışkan G, Girgin NK, Uran İ, Gül B, İşçimen R, Kahveci F (01 Haziran 2014) Hemoperfusion for Theophylline Poisoning: Case Report. Journal of Uludağ University Medical Faculty 40 2 89–93.
IEEE
[1]G. Çalışkan, N. K. Girgin, İ. Uran, B. Gül, R. İşçimen, ve F. Kahveci, “Hemoperfusion for Theophylline Poisoning: Case Report”, Uludağ Tıp Derg, c. 40, sy 2, ss. 89–93, Haz. 2014, [çevrimiçi]. Erişim adresi: https://izlik.org/JA98RB72ZA
ISNAD
Çalışkan, Gülbahar - Girgin, Nermin Kelebek - Uran, İsa - Gül, Bülent - İşçimen, Remzi - Kahveci, Ferda. “Hemoperfusion for Theophylline Poisoning: Case Report”. Journal of Uludağ University Medical Faculty 40/2 (01 Haziran 2014): 89-93. https://izlik.org/JA98RB72ZA.
JAMA
1.Çalışkan G, Girgin NK, Uran İ, Gül B, İşçimen R, Kahveci F. Hemoperfusion for Theophylline Poisoning: Case Report. Uludağ Tıp Derg. 2014;40:89–93.
MLA
Çalışkan, Gülbahar, vd. “Hemoperfusion for Theophylline Poisoning: Case Report”. Journal of Uludağ University Medical Faculty, c. 40, sy 2, Haziran 2014, ss. 89-93, https://izlik.org/JA98RB72ZA.
Vancouver
1.Gülbahar Çalışkan, Nermin Kelebek Girgin, İsa Uran, Bülent Gül, Remzi İşçimen, Ferda Kahveci. Hemoperfusion for Theophylline Poisoning: Case Report. Uludağ Tıp Derg [Internet]. 01 Haziran 2014;40(2):89-93. Erişim adresi: https://izlik.org/JA98RB72ZA

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023